Online protests have stopped Johnson & Johnson from enforcing secondary patents on a critical drug used to treat multidrug-resistant tuberculosis. Joshua Nicholls reports.
Johnson & Johnson
The Indian Patent Office rejected pharmaceutical company Janssen’s application for an extension of its patent on a drug used in the treatment of tuberculosis, reports Peoples Dispatch.